Sort by
Refine Your Search
-
responsibilities The successful candidate will have considerable freedom to shape their research within the broader scope of the laboratory. Potential research directions include: Sources and emissions of indoor air
-
ultrafine particles (UFPs). Main duties and responsibilities The successful candidate will have considerable freedom to shape their research within the broader scope of the laboratory. Potential research
-
by Prof. Marc Gruber, within EPFL's College of Management of Technology. You will have scope to develop your own research agenda and to collaborate with Prof. Gruber and the Chair's researchers
-
conducts applied and theoretical research on the economics and politics of sustainable development, as well as the policies to achieve it. More information at: https://www.epfl.ch/labs/pasu/ . We are looking
-
the earth sciences. NCCR Genesis does not aim to provide answers in all fields, but to drive innovative research and achieve decisive progress. Details on NCCR Genesis are available on its website https
-
opportunities for technology transfer and innovation Competitive salary and excellent working conditions - more information can be found on our website (https://www.epfl.ch/campus/services/human-resources/en
-
than 18,500 people, including over 14,000 students and 4,000 researchers from more than 120 different countries. Postdoc in ML-Based Co-Design at EPFL Mission The EPFL computer vision lab (https://www.epfl.ch
-
Foster ([email protected]) - https://laser.epfl.ch/ Contract Start Date : 01.12.2026, or to be determined Activity Rate : 100.00 Contract Type: CDD Duration: 1 year, renewable Reference: 2464
-
information can be found on https://laser.epfl.ch/. Contract Start Date : 01.12.2026, or to be determined Activity Rate : 100.00 Contract Type: CDD Duration: 1 year, renewable (project duration permitting
-
protocols. In close collaboration with the lab of George Coukos (https://agora-cancer.ch/laboratory/coukos-lab/ ), we will derive protocols enabling rapid expansion of cancer-specific, autologous TILs